UPXI.NASDAQUpexi, INC

S-1/A: Upexi Pivots to Solana Treasury, Eyes $500M Equity Raise

Sentiment:

Registration Statement Amendment for Resale Offering


Upexi, Inc. is undergoing a significant strategic shift from consumer products to a Solana-focused digital asset treasury, supported by recent capital raises and a new $500 million equity facility.

Capital raiseA $500 million Common Stock Purchase Agreement with A.G.P./Alliance Global Partners, allowing the company to sell up to 83,333,333 shares of common stock over a 12-month period, subject to certain conditions and a 19.99% Exchange Cap.A $100 million private placement offering closed on April 24, 2025, involving the sale of 35,970,383 shares of common stock and 7,889,266 pre-funded warrants, yielding approximately $92,586,000 net proceeds to fund the treasury strategy.A $50 million private placement offering closed on July 14, 2025, for 12,457,186 shares of common stock.A $151.2 million secured convertible note offering closed on July 16, 2025, in exchange for locked and spot Solana, secured by a first-priority lien on the company's Digital Asset Account.A credit facility with BitGo Prime, LLC, entered into on May 23, 2025, allows borrowing up to $20,000,000 of Digital Currency or USD at 11.5% interest, collateralized by treasury assets, with initial availability based on a 260% collateral level.

Summary

  • Upexi is transitioning its core business from consumer product development, manufacturing, and distribution to a digital currency holding company, primarily investing in Solana (SOL) tokens and staking them for yield.
  • The company has established a $500 million equity facility with A.G.P./Alliance Global Partners, allowing it to sell up to 83,333,333 shares of common stock over a 12-month period, subject to certain conditions and a 19.99% Exchange Cap.
  • Recent capital raises include a $100 million private placement in April 2025 and a $50 million private placement and $151.2 million convertible note offering in July 2025, with proceeds primarily funding the SOL treasury strategy.
  • As of March 31, 2025, Upexi held 359 Solana Tokens with a carrying value of $44,732, but subsequent to this date, purchased approximately 596,355 Solana Tokens for $84,157,000.
  • Approximately 95% of the SOL treasury is currently staked to earn yield, with a target to maintain a similar or higher percentage.
  • For the three months ended March 31, 2025, revenue declined by 39% to $3,160,480 from $5,223,242 in the prior year, primarily due to a strategic shift away from the recommerce business.
  • Gross profit margin significantly increased to 49% for the three months ended March 31, 2025, compared to 24% in the prior year, despite a decrease in overall gross profit.
  • Net loss from continuing operations improved to $(3,831,660) for the three months ended March 31, 2025, from $(4,118,612) in the prior year.
  • For the nine months ended March 31, 2025, revenue declined by 45% to $11,522,487 from $20,960,812 in the prior year.
  • Gross profit margin for the nine months ended March 31, 2025, increased to 64% from 54% in the prior year, though gross profit decreased by approximately $3,800,000.
  • Net loss from continuing operations improved to $(6,758,547) for the nine months ended March 31, 2025, from $(7,912,919) in the prior year.
  • Working capital deteriorated significantly to $(6,828,044) as of March 31, 2025, from $(1,235,234) at June 30, 2024.
  • The company utilizes third-party qualified custodians like BitGo Trust Company, Inc. and Coinbase, Inc. for its digital assets, with BitGo holding approximately $253 million in treasury value based on a SOL price of $202.51 per token.
  • Insurance policies held by custodians are not adequate to fully cover the current value of the company's SOL holdings.

Sentiment

Score: 4

Explanation: The company is undergoing a high-risk, high-reward strategic pivot into the volatile digital asset market, specifically Solana. While the improved gross margins and reduced net losses are positive, the significant decline in traditional revenue, substantial negative working capital, and inadequate insurance coverage for digital assets present considerable financial and operational challenges. The potential for significant shareholder dilution from the equity facility and regulatory uncertainties in both crypto and CBD markets add to the risk profile. The overall sentiment is cautious due to the magnitude of the strategic shift and the associated uncertainties.

Positives

  • Strategic pivot to a Solana-focused digital asset treasury aims for higher yield on excess cash through staking and purchasing locked Solana at a discount.
  • High percentage of SOL treasury (approximately 95%) is staked to generate yield, turning it into a productive asset.
  • Gross profit margin significantly increased to 49% for the three months ended March 31, 2025, and 64% for the nine months ended March 31, 2025, indicating improved efficiency in the continuing consumer products business.
  • Net loss from continuing operations decreased for both the three and nine months ended March 31, 2025, compared to the prior year periods, showing an improvement in loss reduction.
  • Utilization of multiple qualified custodians (BitGo, Coinbase) and plans to onboard a third custodian to mitigate digital asset treasury risk.
  • Solana is identified as a leading high-performance blockchain with strong network effects, a large and growing ecosystem, and is the #1 ecosystem for new developers in 2024.
  • The company's executive team has strong logistics background, with CEO Allan Marshall being the founder of XPO Logistics, which is a competitive strength in managing supply chain costs.
  • The company controls each phase of its consumer product process from manufacturing to order fulfillment, allowing for cost control and faster product launches.

Negatives

  • Significant revenue decline in the continuing operations, with a 39% decrease for the three months and a 45% decrease for the nine months ended March 31, 2025, primarily due to the strategic shift away from recommerce.
  • Working capital position deteriorated substantially to a deficit of $(6,828,044) as of March 31, 2025, from $(1,235,234) at June 30, 2024.
  • Cash balance decreased by $431,023 to $230,392 as of March 31, 2025, from June 30, 2024.
  • Insurance policies maintained by custodians are not adequate to fully cover the full loss of the company's Solana holdings, posing a significant financial risk.
  • The company recorded a full reserve on accounts receivables owed by Amazon for over 90 days, indicating potential uncollectible funds.
  • Increased legal and auditing costs were incurred during the nine months ended March 31, 2025, related to the change in strategy and restructuring.
  • The potential for substantial dilution to existing stockholders from the issuance of up to 83,333,333 shares under the Purchase Agreement.
  • High turnover among independent distributors is a challenge for maintaining and increasing product sales in the consumer products business.

Risks

  • Inability to predict the actual number of shares sold under the Purchase Agreement or the gross proceeds, leading to uncertainty in liquidity.
  • Substantial dilution to existing stockholders from the sale and issuance of common stock to the Selling Stockholder.
  • Sales of a large number of shares by the Selling Stockholder could depress the market price of common stock.
  • Inability to access the full amount available under the Purchase Agreement could materially adversely affect liquidity.
  • High volatility of Solana (SOL) trading prices, which could lead to a material adverse effect on the value of the shares and potential loss of all or substantially all value.
  • Regulatory uncertainty regarding the classification of Solana and other digital assets as securities, which could subject the company to additional regulation, fines, and penalties.
  • Risk of being deemed an investment company under the 1940 Act, which would impose restrictions making the current business model impractical.
  • Concentration of SOL holdings among a few treasury companies could lead to rapid price declines if any liquidate their positions.
  • Solana holdings are less liquid than cash and cash equivalents and may not be able to serve as a source of liquidity during market instability.
  • Security breaches or cyberattacks on IT systems or third-party custodians could result in partial or total loss of Solana, not fully covered by insurance.
  • Limited operating history in generating staking revenues from Solana makes future performance difficult to forecast.
  • Insufficiently high digital asset awards or transaction fees on the Solana network could disincentivize validators, impacting SOL value.
  • Potential for Maximal Extractable Value (MEV) practices (e.g., sandwich attacks, front-running) to compromise transaction predictability and deter network usage.
  • Competition from other companies staking Solana and from central bank digital currencies (CBDCs) or other digital assets could negatively influence SOL price.
  • Failure to develop and execute successful investment or trading strategies for the digital asset treasury.
  • Trade errors in investment and trading activities could result in material losses.
  • Evolving and uncertain laws and regulations in the CBD industry, including potential classification of hemp products as marijuana, could lead to enforcement actions and operational changes.
  • Unfavorable publicity or consumer perception of hemp-based products could harm reputation and sales.
  • Inability to effectively manage growth, placing strain on managerial, operational, and financial resources.
  • Inability to control costs effectively, potentially leading to sustained losses.
  • Fluctuations in quarterly financial results due to demand changes, inventory management, economic conditions, and marketing costs.
  • Increased costs and demands on management due to compliance with U.S. federal securities laws and Sarbanes-Oxley Act.
  • Cybersecurity breaches of IT systems could degrade business operations, compromise data, and damage reputation.
  • Increases in costs, disruption of supply, or shortage of raw materials (e.g., industrial hemp) could harm the business.
  • Failure to meet Nasdaq Capital Market listing requirements could result in delisting.
  • Loss of key contracts with suppliers or renegotiation on less favorable terms could limit raw material procurement.
  • Limited availability of clinical studies on industrial hemp-based products poses product liability risks.
  • Inability to attract and retain independent distributors for consumer products.
  • Potential obligations resulting from the activities of independent distributors, including reclassification as employees or liability for false claims.
  • Failure of independent distributors to comply with advertising laws and regulations could lead to penalties and recalls.
  • Potential future international expansion could expose the company to additional regulatory risks and compliance costs.

Future Outlook

Management expects general and administrative expenses to return to normal levels as the restructuring of operations is significantly complete. The direct-to-consumer business is anticipated to be the primary growth driver for the next several years, with additional brands and products. The company plans to utilize intelligent capital markets issuance, including equity and convertible debt, to purchase and hold more Solana, aiming for accretive value for shareholders. The company intends to maintain a similar or higher percentage of its SOL treasury staked (currently 95%) and will purchase locked Solana at a discount for higher gains.

Management Comments

  • Management has augmented the overall strategy of the Company to focus on product sales, including the development, production and distribution of branded products.
  • Management will focus its resources to this digital asset strategy and a significant portion of the balance sheet will be allocated to holding Solana in the Company's digital asset treasury.
  • We plan to utilize intelligent capital markets issuance – including the issuance of both equity and convertible debt – where we may issue capital in an accretive fashion for the benefit of shareholders to purchase and hold more Solana.
  • We will stake the majority of the Solana in our treasury to earn a staking yield and turn the treasury into a productive asset. Currently we are staking approximately 95% of our SOL treasury, and intend to maintain a similar or higher percentage going forward.
  • We do not hedge our SOL and do not have plans to hedge our SOL in the future.
  • We will purchase locked Solana at a discount to the current spot price, which will provide higher gains for our shareholders as the discount moves to par over time.
  • Management expects that these declines [in revenue] are temporary as the primary factor was the transition and consolidation of the business to facilities in Florida.
  • Management expects that general and administrative expenses to return to normal levels as the restructuring of the operations is significantly complete as of May 1, 2025 and reserves have been already been increased to reserve assets that may not be fully realized.

Industry Context

The company's pivot to a Solana-focused treasury aligns with the growing interest in digital assets, particularly high-performance blockchains. Solana is highlighted as a leading second-generation blockchain with technical advantages like proof-of-history and parallel transaction execution, fostering a vibrant ecosystem for DeFi, DePIN, AI agents, social media, and gaming. It is noted as the #1 ecosystem for new developers in 2024, indicating strong growth potential. However, the digital asset industry faces significant regulatory uncertainty, with evolving laws and potential classification of digital assets as securities. The consumer products business, particularly hemp-based products, operates in a highly competitive and rapidly evolving market subject to extensive federal and state regulations (FDA, FTC, USDA), with ongoing uncertainty regarding CBD's regulatory status.

Comparison to Industry Standards

  • Solana's proof-of-history mechanism and parallel transaction execution are cited as technical advantages compared to many smart contract blockchain peers that often use single-threaded virtual machines, enabling immense speed and increased throughput.
  • Solana is positioned as optimally along the 'Blockchain Trilemma' by optimizing for speed and security, with natural growth into decentralization.
  • According to Electric Capital's 2024 Developer Report, Solana is the #1 ecosystem for new developers, growing 83% in 2024, which is considered a leading indicator of blockchain growth.
  • Solana often leads all blockchains in key metrics such as daily active users, decentralized application revenues, and decentralized exchange volumes, sometimes surpassing all other chains combined.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Strategy OfficerNABrian Rudick2025-05-22Newly appointed, bringing expertise in traditional finance and crypto.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Committee EstablishmentAudit Committee, Compensation Committee, and Nomination and Governance Committee were established by the Board on January 27, 2021.2021-01-27Enhances corporate oversight and adherence to public company governance standards.
Audit Committee Financial ExpertMr. Lawrence Dugan serves as chairman of the audit committee and has been determined to be an audit committee financial expert.2021-01-27Ensures specialized financial expertise in audit oversight, meeting SEC and Nasdaq requirements.
Equity Incentive Plan AmendmentThe 2019 Equity Incentive Plan was amended in June 2025 to increase the number of shares available for issuance to 10,000,000.2025-06Provides more flexibility for equity-based compensation to attract and retain talent, but also increases potential for future dilution.

Legal Proceedings

  • A complaint was filed by the company in the United States District Court for the District of Nevada to eliminate potential dilution risk related to the issuance of fractional shares from the reverse stock split.

Related Party Transactions

  • On April 1, 2024, the company entered into a five-year lease agreement for a 10,000 square foot facility in Odessa, Florida, with MFA 2510 Merchant LLC, an entity owned by CEO Allan Marshall, for $20,060 per month.
  • On June 13, 2024, CEO Allan Marshall was one of three investors who purchased VitaMedica, Inc., a wholly-owned subsidiary, from the company for $6,000,000.
  • A promissory note (Marshall Loan) with CEO Allan Marshall, originally for $1,500,000, was amended on November 15, 2023, with $500,000 principal outstanding at March 31, 2025, bearing 12% cash interest.
  • CEO Allan Marshall advanced the company $100,000 in June 2024 (repaid in July 2024) and $400,000 subsequent to December 31, 2024, to cover short-term negative cash flow.
  • On March 12, 2025, Allan Marshall purchased 125,000 shares of Series A preferred stock from the company, settled by the cancellation of the $400,000 advance.
  • On April 23, 2025, the company entered into an Asset Management Agreement with GSR Strategies LLC, where GSR Strategies LLC provides discretionary investment management services for the company's cryptocurrency treasury for an annual asset-based fee of 1.75% and received warrants to purchase 2,192,982 shares of common stock.
  • GSR Growth Investments LP, a related party of GSR Strategies LLC, holds 2,306,060 shares of common stock, representing 6.03% of the company's outstanding common stock as of June 30, 2025.

Stakeholder Impact

  • Shareholders face significant potential dilution from the up to 83,333,333 shares offered under the Purchase Agreement and other recent equity issuances.
  • Shareholders are exposed to high volatility and regulatory risks associated with the company's new digital asset treasury strategy, particularly its focus on Solana.
  • Employees may benefit from incentive-restricted stock grants under the 2019 Equity Incentive Plan, but the strategic shift could also lead to changes in the workforce composition.
  • Customers of the consumer products business may experience changes in product offerings and distribution as the company re-prioritizes its business segments.
  • Suppliers of raw materials for the consumer products business may face renegotiation of terms or loss of contracts due to the company's strategic shifts and cost control efforts.
  • Creditors are impacted by the company's increased debt through convertible notes and credit facilities, as well as the overall financial health and liquidity challenges.

Next Steps

  • File additional registration statements if the company elects to sell more than 83,333,333 shares of common stock under the Purchase Agreement.
  • Continue to onboard additional qualified custodians as part of the risk management process for the Solana treasury.
  • Launch the new PRAX brand with several innovative products in October 2024.
  • Continue direct-to-consumer expansion for its brands portfolio.
  • Focus on talent acquisition to support growth across various industries.
  • Management expects general and administrative expenses to return to normal levels as restructuring is completed by May 1, 2025.

Key Dates

DateDescription
2020-07Company purchased Infusionz LLC.
2021-02-08Shareholders consented and Board approved amendment of 2019 Plan to increase maximum shares to 277,778.
2021-06Upexi Inc. became a listed company on the Nasdaq stock exchange.
2021-08Company purchased assets of VitaMedica Corporation.
2021-10Company purchased Interactive Offers, LLC.
2022-04Company purchased 55% of Cygnet Online, LLC.
2022-05-24Shareholders consented and Board approved amendment of 2019 Plan to increase maximum shares to 500,000.
2022-06Company entered into a securities purchase agreement for up to $15,000,000 in convertible notes and warrants.
2022-06Company executed a promissory note (Marshall Loan) with CEO Allan Marshall for $1,500,000.
2022-08Company purchased assets to the brand LuckyTail.
2022-10Company purchased E-Core Technology, Inc. d/b/a New England Technology, Inc.
2022-10Company sold all rights to Infusionz brands and manufacturing business.
2022-10-19Company entered into a loan agreement with Professional Bank for a $3,000,000 mortgage on its N. Clearwater, Florida office.
2022-10-28Company accepted an offer to sell Infusionz, LLC and certain manufacturing operations to Bloomios, Inc.
2023-02-22Company executed a promissory note with an investor for $560,000.
2023-02-22Company executed a promissory note with an investor for $2,150,000.
2023-03-15Company entered into a lease for approximately 20,400 square feet of warehouse and office space in Tampa, Florida.
2023-07Company notified the buyer of Infusionz brands of defaults and terminated obligations, restarting manufacturing for its own brands.
2023-07-25Company entered into a lease for approximately 5,700 square feet of office space in Tampa, Florida, for its corporate headquarters.
2023-08Company purchased the remaining ownership of Cygnet.
2023-08Company sold 100% of the equity of its wholly owned subsidiary Interactive Offers, LLC.
2023-09-01Company completed the acquisition of the remaining 45% interest in Cygnet Online, LLC.
2023-11-15Company executed an amendment to the promissory note with Mr. Marshall, extending the term and adjusting interest.
2023-11-15Company executed an amendment to the promissory note with an investor, extending the term and adjusting interest.
2024-01-18Company issued 25,081 shares of common stock as repayment of $500,000 of long-term debt.
2024-03-18Company issued 5,000 shares of common stock as an incentive-restricted stock grant.
2024-04-01Company entered into a lease agreement with MFA 2510 Merchant LLC (owned by CEO Allan Marshall) for a facility in Odessa, Florida.
2024-05Company sold its equity interest in the wholly owned subsidiary VitaMedica.
2024-06Company sold its equity interest in the wholly owned subsidiary E-Core Technology, Inc.
2024-062019 Equity Incentive Plan was amended to increase shares available for issuance to 10,000,000.
2024-06-13Company entered into a Stock Purchase Agreement to sell VitaMedica, Inc.
2024-07-08The building collateralizing the mortgage loan with Professional Bank was sold for $4,300,000.
2024-08-01Company closed a sale transaction for E-Core Technology, Inc., effective June 30, 2024.
2024-08-01Product manufacturing at Gumi Labs facility in Odessa, Florida, was at full capacity and fully moved from the Nevada facility.
2024-09-18Company filed a Certificate of Change for a 1-for-20 reverse stock split.
2024-10-03Reverse Stock Split became effective.
2024-10-17Company received notice from Nasdaq that it regained compliance with the minimum bid price rule.
2025-01Company announced the strategy of establishing a digital currency holding company to invest in cryptocurrency.
2025-01Company issued 260,000 shares of common stock for repayment of $550,000 of outstanding debt.
2025-01Company issued 220,000 shares of common stock as incentive-restricted stock grants.
2025-02Company issued 125,000 shares of common stock for repayment of $250,000 of outstanding debt.
2025-02Company issued 4,000 shares of common stock as an incentive-restricted stock grant.
2025-03-07Company executed a convertible note with two investors for $350,000.
2025-03-12CEO Allan Marshall purchased 125,000 shares of Series A preferred stock by canceling a $400,000 advance.
2025-03-31End of the nine-month interim financial reporting period.
2025-04Company consummated a $100 million private placement offering to fund its treasury strategy.
2025-04-17Company issued restricted stock grants of 222,000 shares of common stock under the 2019 Incentive Plan.
2025-04-23Company entered into an Asset Management Agreement with GSR Strategies LLC.
2025-04-24Company closed on a private placement offering of 35,970,383 shares of common stock and 7,889,266 pre-funded warrants.
2025-04-24Company issued 214,228 shares of common stock as repayment of $550,000 of debt.
2025-04-24Company entered a new employment agreement with Allan Marshall, Chairman and Chief Executive Officer.
2025-04-24Company entered an employment agreement with Andrew Norstrud, Chief Financial Officer.
2025-05-01Company entered into a Custodial Services Agreement with BitGo Trust Company, Inc.
2025-05-05Company entered into an Institutional Client Agreement with Coinbase Inc.
2025-05-22Brian Rudick appointed Chief Strategy Officer.
2025-05-23Company entered into a credit facility with BitGo Prime, LLC for up to $20,000,000.
2025-07Company consummated a $50 million private placement offering and a $151.2 million convertible note offering.
2025-07-11Company entered into securities purchase agreements for a $50 million private placement offering.
2025-07-16Company entered into securities purchase agreements for a $151.2 million secured convertible note offering.
2025-07-17Company issued restricted stock grants of 2,250,000 shares of common stock under the 2019 Incentive Plan.
2025-07-25Company entered into a Common Stock Purchase Agreement and a Registration Rights Agreement with A.G.P./Alliance Global Partners.
2025-08-08Legal opinion date for the S-1/A filing.
2025-08-25Company and purchasers agreed to amend the Securities Purchase Agreement dated July 11, 2025.
2025-09-23Closing price of common stock on Nasdaq was $6.17 per share.
2025-09-24Filing date of the S-1/A Amendment No. 4.

Recommendation

hold

The company is undergoing a radical strategic pivot from a traditional consumer products business to a Solana-focused digital asset treasury. This introduces a new, highly volatile, and regulatory-uncertain risk profile. While the improved gross profit margins and reduced net losses in continuing operations are positive, the significant revenue decline and substantial negative working capital indicate ongoing operational challenges in the legacy business. The large potential dilution from the $500 million equity facility and the inadequate insurance coverage for the substantial Solana holdings are major concerns. A 'Hold' recommendation is appropriate for a seasoned investor, allowing time to observe the execution and success of the new digital asset strategy, the stabilization of the consumer products segment, and the resolution of regulatory uncertainties, without committing additional capital or exiting prematurely given the potential for long-term appreciation in Solana.

Keywords

Solana, Cryptocurrency, Digital Assets, Staking, Blockchain, Consumer Products, E-commerce, SEC Filing, S-1/A, Equity Offering, Private Placement, Convertible Notes, Risk Management, Corporate Governance, Hemp Products, CBD, Nasdaq

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.